Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound.

MLA

Verhulst, Anja, et al. “Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound.” PLoS ONE, vol. 10, no. 3, Mar. 2015, pp. 1–19. EBSCOhost, https://doi.org/10.1371/journal.pone.0121861.

APA

Verhulst, A., Sun, S., McKenna, C. E., & D, H. P. C. (2015). Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound. PLoS ONE, 10(3), 1–19. https://doi.org/10.1371/journal.pone.0121861

Chicago

Verhulst, Anja, Shuting Sun, Charles E. McKenna, and Haese, Patrick C. D. 2015. “Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound.” PLoS ONE 10 (3): 1–19. doi:10.1371/journal.pone.0121861.